Enzyme Finance (formerly Melon Protocol) is an on-chain fund management protocol that allows professional asset managers to create transparent, auditable investment funds on Ethereum — where all positions, fees, and strategies are visible on-chain and investors can withdraw at any time without counterparty risk. MLN is the fee token: on every investment and redemption, a small MLN fee is burned, creating a deflationary mechanism tied to protocol usage. Protocol treasuries (like Aave DAO), DeFi hedge funds, and individual managers use Enzyme to deploy capital across Uniswap, Aave, Compound, and other integrated protocols. Founded by Reto Trinkler and Mona El Isa (former Goldman Sachs), Enzyme is one of the oldest active DeFi protocols still in production.
| Stat | Value |
|---|---|
| Ticker | MLN |
| Price | $3.13 |
| Market Cap | $10.26M |
| 24h Change | +0.2% |
| Circulating Supply | 3.28M MLN |
| All-Time High | $258.26 |
| Contract (Ethereum) | 0xec67...1892 |
| Contract (Polygon Pos) | 0xa9f3...e207 |
| Contract (Arbitrum One) | 0x8f5c...b514 |
How It Works
Non-custodial funds:
Each Enzyme Vault is a smart contract that holds assets on behalf of investors. The fund manager controls the investment strategy but cannot steal funds because:
- Withdrawals go directly to investors at any time
- Fund manager actions are constrained by on-chain rules the manager configured at setup
Integrated DeFi protocols:
Enzyme integrates 300+ DeFi adapters, allowing fund managers to:
- Trade on Uniswap v2/v3, Curve, 0x
- Lend on Aave, Compound
- Stake in Convex, Yearn Vaults
- Hold LSTs (stETH, rETH)
- Use options (Lyra, Opyn)
MLN burn mechanism:
A small MLN fee is charged on every Enzyme transaction and burned, reducing total MLN supply over time. This ties MLN value to protocol AUM and activity.
Sulu and Verdant upgrades:
Regular Enzyme protocol versions (named after Star Trek characters) add new integrations, performance fee options, and governance controls.
Tokenomics
| Metric | Value |
|---|---|
| Supply | ~1.3M MLN (very low supply, high per-token value historically) |
| Inflation | Small annual issuance for developer grants |
| Burn | MLN burned on every protocol transaction |
| ATH | ~$1,800 (Feb 2018, before DeFi era) |
| AUM managed | Hundreds of millions in peak periods |
Use Cases
- Protocol fee — MLN burned on every Enzyme vault transaction
- Developer grants — MLN issued to contributors building on Enzyme
- Governance — MLN holders vote on protocol upgrades and new integrations
- On-chain funds — Investors access diversified strategies via Enzyme vaults
History
- 2016 — Melon Protocol (later Enzyme) conceptualized by Reto Trinkler
- 2017 — Melon Protocol ICO; one of Ethereum’s first DeFi protocols
- Mar 2017 — MLN token launches
- 2018 — Melon mainnet v1 launches; niche adoption by early DeFi users
- 2019 — Melon Council governance forms
- 2021 — Rebrands to “Enzyme Finance”; protocol revamp dramatically increases integrations
- 2021 — Enzyme v4 (Sulu); AUM peaks at $200M+
- 2022–2024 — Enzyme Verdant launch; continued DeFi protocol integration expansion; DAO treasury use cases
Common Misconceptions
“Enzyme manages money like a bank.” Enzyme is entirely non-custodial — no human ever holds investor funds. All capital sits in smart contracts with on-chain withdrawal rights, not in Enzyme’s corporate accounts.
“Low MLN price means the protocol is failing.” MLN’s burn mechanism means its value tracks protocol usage volume, not speculative momentum. A declining price alongside stable AUM reflects bear market conditions, not fundamental problems.